Spravato 28 mg nasal spray (each device delivers two sprays containing a total of 28 mg of esketamine) Images
Generic Name: esketamine
This medication has been identified as Spravato 28 mg nasal spray (each device delivers two sprays containing a total of 28 mg of esketamine). It is supplied by Janssen Pharmaceuticals, Inc.
Spravato is used in the treatment of Major Depressive Disorder; Depression and belongs to the drug class miscellaneous antidepressants. Spravato 28 mg nasal spray (each device delivers two sprays containing a total of 28 mg of esketamine) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images of medication
Spravato
- Generic Name
- esketamine
- Strength
- 28 mg nasal spray (each device delivers two sprays containing a total of 28 mg of esketamine)
- Availability
- Prescription only
- Drug Class
- Miscellaneous antidepressants
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0028
More about Spravato (esketamine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (125)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antidepressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.